468 related articles for article (PubMed ID: 15176942)
1. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.
Hewlett AT
Expert Opin Biol Ther; 2009 Sep; 9(9):1235-40. PubMed ID: 19601727
[TBL] [Abstract][Full Text] [Related]
3. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
Beran J
Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
6. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
7. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
8. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
[TBL] [Abstract][Full Text] [Related]
9. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
[TBL] [Abstract][Full Text] [Related]
11. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
12. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
[No Abstract] [Full Text] [Related]
13. Immunogenicity of Twinrix in older adults: a critical analysis.
Stoffel M; Lievens M; Dieussaert I; Martin I; André F
Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
15. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
Keystone JS; Hershey JH
Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
17. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
Proell S
BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
[No Abstract] [Full Text] [Related]
18. [Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].
Tatochenko VK; Il'ina NI; Romanenko VV; Alikova OA; Fassakhov RS; Miasnikova TN; Patlusova VV; Zima IuIu; Reshetnikova ID; Frolova GS; Smolenov IV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):30-5. PubMed ID: 17163135
[TBL] [Abstract][Full Text] [Related]
19. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
[TBL] [Abstract][Full Text] [Related]
20. [Acute hepatitis A despite combined vaccination against hepatitis A and B--re the article from DMW 30/2002, page 1581-3].
Lander T
Dtsch Med Wochenschr; 2002 Nov; 127(46):2466-7; author reply 2467. PubMed ID: 12432491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
